Wellington Management Takes 10% Stake in Amicus Therapeutics

TL;DR

**Wellington Management just disclosed a 10% stake in Amicus Therapeutics, signaling big institutional confidence.**

AI Summary

Wellington Management Group LLP, a major investment firm, reported on February 8, 2024, that it beneficially owns 10.0% of Amicus Therapeutics, Inc.'s common stock, totaling 30,000,000 shares. This significant stake, established as of December 29, 2023, indicates Wellington's strong conviction in Amicus Therapeutics, a pharmaceutical company. For current or prospective shareholders, this filing signals that a large institutional investor sees value in Amicus, potentially boosting confidence in the stock's future performance.

Why It Matters

This filing reveals a major institutional investor's significant belief in Amicus Therapeutics, which can be a positive signal for other investors and potentially influence stock price.

Risk Assessment

Risk Level: low — This filing indicates a large institutional investment, generally seen as a positive sign, reducing perceived risk.

Analyst Insight

A smart investor would view this as a positive signal, potentially indicating a strong institutional belief in Amicus Therapeutics' future, and might consider further research into the company's fundamentals.

Key Numbers

• 30,000,000 — Shares Beneficially Owned (Represents the total number of common stock shares of Amicus Therapeutics, Inc. held by Wellington Management Group LLP.)
• 10.0% — Percentage of Class (Indicates the significant ownership stake Wellington Management Group LLP has in Amicus Therapeutics, Inc.)

Key Players & Entities

• Wellington Management Group LLP (company) — the reporting person and institutional investor
• AMICUS THERAPEUTICS, INC. (company) — the subject company whose stock was acquired
• 30,000,000 (dollar_amount) — number of shares beneficially owned
• 10.0% (dollar_amount) — percentage of class beneficially owned
• December 29, 2023 (dollar_amount) — date of event requiring the filing
• February 8, 2024 (dollar_amount) — filing date

Forward-Looking Statements

• Amicus Therapeutics' stock price may see increased investor confidence due to this significant institutional stake. (AMICUS THERAPEUTICS, INC.) — medium confidence, target: Q2 2024

FAQ

Filing Documents

• SEC13G_Filing.htm (SC 13G) — 35KB
• 0000902219-24-000043.txt ( ) — 37KB

From the Filing

SC 13G 1 SEC13G_Filing.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. _ ) * AMICUS THERAPEUTICS, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 03152W109 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes.) CUSIP No. 03152W109 1. NAMES OF REPORTING PERSONS Wellington Management Group LLP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Massachusetts NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 13,984,290 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 15,190,024 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 15,190,024 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.18% 12. TYPE OF REPORTING PERSON HC CUSIP No. 03152W109 1. NAMES OF REPORTING PERSONS Wellington Group Holdings LLP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 13,984,290 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 15,190,024 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 15,190,024 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.18% 12. TYPE OF REPORTING PERSON HC CUSIP No. 03152W109 1. NAMES OF REPORTING PERSONS Wellington Investment Advisors Holdings LLP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 13,984,290 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 15,190,024 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 15,190,024 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.18% 12. TYPE OF REPORTING PERSON HC CUSIP No. 03152W109 1. NAMES OF REPORTING PERSONS Wellington Management Company LLP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 13,949,616 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 14,814,529 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 14,814,529 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.05% 12. TYPE OF REPORTING PERSON IA Item 1. (a) Name of Issuer AMICUS THERAPEUTICS, INC. (b) Address of Issuer's Principal Executive Offices 3675 Market Street Philadelphia, PA 19104 Item 2. (a) Name of Person Filing Wellington Management Group LLP Wellington Group Holdings LLP Wellington Investment Advisors Holdings LLP Wellington Management Company LLP (b) Address of Principal Business Office or, if None, Residence c/o Wellington Management Company LLP 280 Congress Street Boston, MA 02210 (c) Citizenship Wellington Management Group LLP - Massachusetts Wellington Group Holdings LLP - Delaware Wellington Investment Advisors Holdings LLP - Delaware Wellington Management Company LLP - Delaware (d) Title of Class of Securities Common Stock (e) CUSIP Number 03152W109 Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance Company as

View Full Filing

View this SC 13G filing on SEC EDGAR